Integra LifeSciences (IART) announced that its board of directors has appointed Mojdeh Poul as the new president and CEO, effective January 6, 2025. Poul will also join the Integra board when she assumes the role. She will succeed Jan De Witte, who will remain president and CEO until January 6, 2025. Stuart Essig will remain executive chairman of Integra for a limited period of time before returning to his prior role as non-executive chairman. Most recently, Poul was the executive vice president and group president for 3M’s (MMM) $8.5B Global Healthcare Business, comprised of four business units, including advanced wound care.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IART:
- Integra LifeSciences reports Q3 adjusted EPS 41c, consensus 39c
- Integra Lifesciences (IART) Q3 Earnings Cheat Sheet
- Integra LifeSciences price target lowered to $21 from $26 at Truist
- Integra LifeSciences price target lowered to $18 from $26 at BofA
- Integra LifeSciences upgraded to Neutral from Sell at BTIG